Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Dec 28, 2006
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Although remarkable progress has been made, chronic kidney disease still poses a major burden on both individual patients, as well as on society as a whole. There is a strong inverse relationship between decreasing renal function, as estimated by glomerular filtration rate, and mortality rate, especially death due to cardiovascular disease. The exact cause(s) remain to be elucidated. Uremic toxins might play an important role.
In the course of decreasing renal function the concentration of numerous intracellular and extracellular compounds vary from the non-uremic state. A still increasing...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Start hemodialysis during 2007
- • Age over 18 years
- • Informed consent
- Exclusion Criteria:
- • Non consent
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clayton, Victoria, Australia
Geelong, Victoria, Australia
Leuven, Vlaams Brabant, Belgium
Hasselt, Limburg, Belgium
Patients applied
Trial Officials
Björn KI Meijers, MD
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Pieter Evenepoel, MD, PhD
Study Director
Universitaire Ziekenhuizen KU Leuven
Tom Dejagere, MD
Principal Investigator
Virga Jesse Ziekenhuis
Nigel Toussaint, MD
Principal Investigator
Geelong Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials